Virtus ETF Advisers’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,621
Closed -$87K 490
2022
Q1
$87K Sell
11,621
-692
-6% -$5.73K 0.04% 325
2021
Q4
$172K Buy
12,313
+7,981
+184% +$157K 0.07% 276
2021
Q3
$112K Sell
4,332
-233
-5% -$7.38K 0.05% 374
2021
Q2
$209K Sell
4,565
-4,859
-52% -$230K 0.09% 317
2021
Q1
$415K Buy
9,424
+161
+2% +$7.83K 0.18% 177
2020
Q4
$285K Buy
+9,263
New +$294K 0.12% 235

Other funds holding AMTI

Virtus ETF Advisers's AMTI Position: Q2 2022 in Review

Virtus ETF Advisers sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q2 2022, closing a stake of 11,621 shares — an estimated $87K sold.

Virtus ETF Advisers first reported a position in AMTI in Q4 2020 and held it in 6 quarters. The position peaked at $415K in Q1 2021. 56 funds tracked by Wall St. Rank hold AMTI as of Q2 2022.

  • Virtus ETF Advisers reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 11,621 Applied Molecular Transport Inc. Common Stock shares in Q2 2022, an estimated $87K.
  • Virtus ETF Advisers first reported a position in Applied Molecular Transport Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Virtus ETF Advisers's Applied Molecular Transport Inc. Common Stock position peaked at $415K in Q1 2021.
  • 56 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q2 2022.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.